| |
All patients (n=615) |
NC group (n=87) |
NMS group (n=376) |
MS group (n=239) |
p |
| Age (years) |
59.97 ± 12.02 |
59.21 ± 10.98 |
59.87 ± 11.94 |
60.14 ± 12.16 |
0.821 |
| Male(%) |
53.80% |
52.90% |
50.50% |
59.00% |
0.12 |
| WC (cm) |
89.12 ± 10.36 |
84.46 ± 10.67 |
85.25 ± 9.67 |
95.20 ± 8.27*# |
0 |
| BMI (kg/m2) |
24.38 ± 3.07 |
23.46 ± 2.70 |
23.41 ± 2.87 |
25.90 ± 2.74*# |
0 |
| Smoking (%) |
84(13.7%) |
9(10.3%) |
44(11.7%) |
40(17.4%) |
0.091 |
| Duration of EH(months) |
98.03 ± 24.62 |
|
98.82 ± 26.87 |
96.71 ± 20.97 |
0.804 |
| SBP (mmHg) |
137.68 ± 15.80 |
125.09 ± 10.85 |
137.37 ± 15.81* |
138.16 ± 15.80* |
0 |
| DBP (mmHg) |
80.26 ± 11.45 |
74.30 ± 8.42 |
79.90 ± 11.28* |
80.81 ± 11.69* |
0 |
| HR(beats/min) |
72.37 ± 9.40 |
74.35 ± 11.96 |
72.26 ± 9.10 |
72.54 ± 9.87 |
0.398 |
| TBIL(μmol/L) |
14.75 ± 6.23 |
14.25 ± 5.98 |
15.14 ± 6.60 |
14.13 ± 5.56 |
0.116 |
| CR(μmol/L) |
71.52 ± 19.56 |
62.52 ± 11.51 |
69.89 ± 19.76* |
74.08 ± 19.00*# |
0 |
| Glucose (mmol/l) |
5.90 ± 1.46 |
5.52 ± 1.04 |
5.41 ± .63 |
6.68 ± 1.96*# |
0 |
| TC(mmol/l) |
4.97 ± 1.17 |
5.11 ± 0.98 |
4.92 ± 1.05 |
5.03 ± 1.35 |
0.291 |
| TG (mmol/l) |
1.64 ± 1.13 |
1.46 ± 0.73 |
1.25 ± 0.60 |
2.24 ± 1.45*# |
0 |
| HDL (mmol/l) |
1.44 ± 0.59 |
1.46 ± 0.39 |
1.47 ± 0.42 |
1.39 ± 0.79 |
0.168 |
| WBC (10^9/l) |
6.27 ± 1.72 |
5.53 ± 1.55 |
6.09 ± 1.62* |
6.55 ± 1.84*# |
0 |
| UA (μmol/l) |
368.11 ± 98.89 |
323.77 ± 104.49 |
353.63 ± 92.83* |
390.90 ± 101.42*# |
0 |
| FMD (%) |
8.70 ± 4.43 |
12.03 ± 4.51 |
8.98 ± 4.32* |
8.23 ± 4.58*# |
0 |
| EID (%) |
16.34 ± 7.19 |
18.42 ± 7.75 |
16.64 ± 7.49* |
15.87 ± 6.67* |
0.019 |
| Medication (%) |
|
| ACEI/ARB |
242(39.3%) |
|
140(37.2%) |
102(42.7%) |
0.204 |
| Beta-blocker |
129(21.0%) |
|
77(20.5%) |
52(21.8%) |
0.761 |
| CCB |
218(35.4%) |
|
132(35.1%) |
86(36.0%) |
0.863 |
| Statins |
169(27.5%) |
|
98(26.1%) |
71(29.7%) |
0.354 |
| Diabetes (%) |
23(3.7%) |
|
12(3.2%)* |
61(25.5%)*# |
0.008 |
| HUA% |
240(39.0%) |
4(4.6%) |
120(31.9%)* |
120(50.2%)*# |
0 |
| NC: Normal Control; NMS:Hypertensives without Metabolic Syndrome; MS:Hypertensives with Metabolic Syndrome; WC:Waist Circumference; BMI:Body Mass Index; EH:Essential Hypertension; SBP:Systolic Blood Pressure; DBP:Diastolic Blood Pressure; HR:Heart Rate; TBIL:Total Bilirubin; CR:Creatinine; TC:Total Cholesterol; TG:Triglyceride; HDL:High-Density Lipoprotein; WBC:White Blood Cells; UA:Uric Acid; FMD:Flow Mediated Dilatation; EID:Endothelium-Independent Dilatation; ACEI:Angiotensin Converting Enzyme Inhibitors; ARB:Angiotensin Receptor Blockers; CCB:Calcium-Channel Blocker; MS:Metabolic Syndrome; HUA:Hyperuricemia; *P<0.05 compared to controls:#P<0.05 compared to NMS group. |
|
